SEC Form 4 · accession 0000905718-16-001106
LIBERATOR MEDICAL HOLDINGS, INC. · LBMH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Leger
Officer — Chief Operating Officer
Period of report
Jan 21, 2016
Accepted (ET)
Jan 22, 2016 · 8:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000017485
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 21, 2016 | D | 235,165 | $3.35 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $0.97 | Jan 21, 2016 | D | 45,000 | D | — | Feb 14, 2018 | Common Stock | 45,000 | 0 | D |
Explanation of responses
- F1The shares were disposed of in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of November 19, 2015, by and among Liberator Medical Holdings, Inc. (the "Company"), C. R. Bard, Inc. and Freedom MergerSub, Inc. Upon consummation of the merger, each share of the Company's common stock was converted into the right to receive $3.35 in cash (the "Merger Consideration"), subject to any applicable withholding taxes.
- F2These options were canceled in the merger in exchange for a cash payment of $107,100, representing the difference between the Merger Consideration and the per share exercise price of the options on the effective date of the merger multiplied by the number of shares subject to the option ($2.38 per share).